Skip to content
Screener

Amgen AMGN Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$73K+462%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$19.7M+41.7%
Roivant Sciences logo
Roivant SciencesROIV
$419K-89.6%
Pfizer logo
PfizerPFE

Other financials

Income statement

See full
Revenue$10.1B+9.5%
Gross profit$7.2B+17.4%
Operating income$3.5B+32.3%
Net income$2.4B+65.9%
EPS (diluted)$4.37+64.9%

Balance sheet

See full
Cash & equivalents$574.0M+5.9%
Total debt$57.3B+2.0%
Total equity$11.7B+57.4%
Total assets$95.6B+8.8%

Cash flow

See full
Operating cash flow$4.0B+75.5%
CapEx$513.0M+39.0%
Free cash flow$3.5B+82.6%

Valuation

See full
Market cap$222.32B+43.3%
Enterprise value$279.05B+32.4%
P/E25.4×+2.0×
P/S5.8×+1.4×

Profitability

See full
Gross margin69.5%+5.0pp
Operating margin30%+6.5pp
Net margin23%+4.0pp
FCF margin26.7%-3.7pp

Returns & leverage

See full
Return on equity91.5%-7.7pp
Debt / equity4.9×-2.7×
Current ratio1.4×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Amgen’s 10-Q, filed August 5, 2026.

Filed
Aug 4, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000318154-26-000126
Line itemSix months ended June 30, 2026Six months ended June 30, 2025
Other liabilities(107)(70)
Net cash provided by operating activities6,1913,671
Cash flows from investing activities:
Purchases of property, plant and equipment(1,225)(780)
Other(60)(56)
Net cash used in investing activities(1,285)(836)
Cash flows from financing activities:
Net proceeds from issuance of debt3,964

Item 1. FINANCIAL STATEMENTS

FAQ

What is Amgen's payments to acquire property, plant, and equipment?
Amgen (AMGN) reported payments to acquire property, plant, and equipment of $513M in Q2 2026.
How has Amgen's payments to acquire property, plant, and equipment changed year-over-year?
Amgen's payments to acquire property, plant, and equipment increased by 39.0% year-over-year, from $369M to $513M.
What is the long-term trend for Amgen's payments to acquire property, plant, and equipment?
Over 4 years (2021 to 2025), Amgen's payments to acquire property, plant, and equipment has grown at a 20.5% compound annual growth rate (CAGR), from $880M to $1.86B.
What does payments to acquire property, plant, and equipment mean?
Payments to Acquire Property, Plant, and Equipment

Ask your AI about Amgen's payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude